| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms.
|
J Clin Gastroenterol
|
2004
|
1.50
|
|
2
|
Two new bicyclic cembranolides from a new Sarcophyton species and determination of the absolute configuration of sarcoglaucol-16-one.
|
Org Biomol Chem
|
2004
|
1.03
|
|
3
|
Proximicin A, B and C, novel aminofuran antibiotic and anticancer compounds isolated from marine strains of the actinomycete Verrucosispora.
|
J Antibiot (Tokyo)
|
2008
|
1.01
|
|
4
|
Integrated approach to explore the potential of marine microorganisms for the production of bioactive metabolites.
|
Adv Biochem Eng Biotechnol
|
2002
|
0.98
|
|
5
|
Localization, trafficking, and significance for acid secretion of parietal cell Kir4.1 and KCNQ1 K+ channels.
|
Gastroenterology
|
2008
|
0.98
|
|
6
|
Prevalence of Helicobacter pylori and occurrence of gastroduodenal lesions in patients with liver cirrhosis.
|
Int J Clin Exp Med
|
2010
|
0.95
|
|
7
|
Novel caprolactones from a marine streptomycete.
|
J Nat Prod
|
2004
|
0.92
|
|
8
|
Caboxamycin, a new antibiotic of the benzoxazole family produced by the deep-sea strain Streptomyces sp. NTK 937.
|
J Antibiot (Tokyo)
|
2009
|
0.92
|
|
9
|
Proximicins A, B, and C-antitumor furan analogues of netropsin from the marine actinomycete Verrucosispora induce upregulation of p53 and the cyclin kinase inhibitor p21.
|
Angew Chem Int Ed Engl
|
2008
|
0.88
|
|
10
|
Peptide-mediated disruption of NFkappaB/NRF interaction inhibits IL-8 gene activation by IL-1 or Helicobacter pylori.
|
J Immunol
|
2007
|
0.88
|
|
11
|
Oxazatricyclic noradamantanes: stereocontrolled synthesis of functionalized scopolines, related cage molecules, and drug leads.
|
Org Lett
|
2004
|
0.88
|
|
12
|
Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions.
|
Expert Opin Drug Metab Toxicol
|
2009
|
0.87
|
|
13
|
Lactonamycin Z, an antibiotic and antitumor compound produced by Streptomyces sanglieri strain AK 623.
|
J Antibiot (Tokyo)
|
2003
|
0.85
|
|
14
|
Aspochalamins A-D and aspochalasin Z produced by the endosymbiotic Fungus aspergillus niveus LU 9575. I. Taxonomy, fermentation, isolation and biological activities.
|
J Antibiot (Tokyo)
|
2004
|
0.84
|
|
15
|
Effect of H. pylori on the expression of TRAIL, FasL and their receptor subtypes in human gastric epithelial cells and their role in apoptosis.
|
Helicobacter
|
2004
|
0.84
|
|
16
|
Improved production of bioactive glucosylmannosyl-glycerolipid by sponge-associated Microbacterium species.
|
Mar Biotechnol (NY)
|
2004
|
0.84
|
|
17
|
Pyrocoll, an antibiotic, antiparasitic and antitumor compound produced by a novel alkaliphilic Streptomyces strain.
|
J Antibiot (Tokyo)
|
2003
|
0.83
|
|
18
|
Differential glucocorticoid effects on repair mechanisms and NF-kappaB activity in the intestinal epithelium.
|
Regul Pept
|
2002
|
0.83
|
|
19
|
Retymicin, galtamycin B, saquayamycin Z and ribofuranosyllumichrome, novel secondary metabolites from Micromonospora sp. Tü 6368. I. Taxonomy, fermentation, isolation and biological activities.
|
J Antibiot (Tokyo)
|
2005
|
0.82
|
|
20
|
New aminophenoxazinones from a marine Halomonas sp.: fermentation, structure elucidation, and biological activity.
|
J Antibiot (Tokyo)
|
2006
|
0.81
|
|
21
|
Nataxazole, a new benzoxazole derivative with antitumor activity produced by Streptomyces sp. Tü 6176.
|
J Antibiot (Tokyo)
|
2008
|
0.81
|
|
22
|
Differential effects of multiplicity of infection on Helicobacter pylori-induced signaling pathways and interleukin-8 gene transcription.
|
J Clin Immunol
|
2010
|
0.81
|
|
23
|
Fluostatins C-E, novel members of the fluostatin family produced by Streptomyces strain Acta 1383.
|
J Antibiot (Tokyo)
|
2006
|
0.80
|
|
24
|
New cytotoxic cembrane based diterpenes from the soft corals Sarcophyton cherbonnieri and Nephthea sp.
|
Org Biomol Chem
|
2003
|
0.80
|
|
25
|
Aranciamycin anhydride, a new anthracycline-type antibiotic isolated from Streptomyces sp. Tü 6384(*).
|
J Antibiot (Tokyo)
|
2010
|
0.80
|
|
26
|
CYP2C metabolism of oral antidiabetic drugs--impact on pharmacokinetics, drug interactions and pharmacogenetic aspects.
|
Expert Opin Drug Metab Toxicol
|
2012
|
0.78
|
|
27
|
Piceamycin and its N-acetylcysteine adduct is produced by Streptomyces sp. GB 4-2.
|
J Antibiot (Tokyo)
|
2009
|
0.78
|
|
28
|
Nocardichelins A and B, siderophores from Nocardia strain acta 3026.
|
J Nat Prod
|
2007
|
0.78
|
|
29
|
Elloxazinones A and B, New Aminophenoxazinones from Streptomyces griseus Acta 2871.
|
J Antibiot (Tokyo)
|
2007
|
0.78
|
|
30
|
Helicobacter pylori -induced apoptosis in gastric epithelial cells is blocked by protein kinase C activation.
|
Microb Pathog
|
2002
|
0.77
|
|
31
|
Ripromycin and other polycyclic macrolactams from Streptomyces sp. Tü 6239: taxonomy, fermentation, isolation and biological properties.
|
J Antibiot (Tokyo)
|
2003
|
0.77
|
|
32
|
Experimental Helicobacter pylori infection induces antral-predominant, chronic active gastritis in hispid cotton rats (Sigmodon hispidus).
|
Helicobacter
|
2005
|
0.76
|
|
33
|
In vitro inhibition of Helicobacter pylori growth and adherence to gastric mucosal cells by Pycnogenol.
|
Phytother Res
|
2008
|
0.76
|
|
34
|
Stringent time-dependent transregulation of calcium calmodulin kinase II (CaMKII) is implicated in anti-apoptotic control.
|
Biochim Biophys Acta
|
2007
|
0.75
|
|
35
|
Severe hypoglycemia due to possible interaction between glibenclamide and sorafenib in a patient with hepatocellular carcinoma.
|
Curr Drug Saf
|
2013
|
0.75
|
|
36
|
Synthesis and evaluation of a netropsin-proximicin-hybrid library for DNA binding and cytotoxicity.
|
Bioorg Med Chem Lett
|
2009
|
0.75
|